Royal Bank Of Canada Decibel Therapeutics, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.41 - $4.81 $761 - $1,519	-316 Reduced 30.44%	722 $2,000
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $1,697 - $3,908	816 Added 367.57%	1,038 $3,000
Q4 2022 Feb 14, 2023	BUY	$1.86 - $3.54 $254 - $484	137 Added 161.18%	222 $0
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $324 - $476	85 New	85 $0
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $3,042 - $5,407	-1,075 Closed	0 $0

Q4 2021 Feb 14, 2022	SELL	$4.57 - $8.58 $4,570 - $8,580	-1,000 Reduced 48.19%	1,075 $5,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $9.04 $1,775 - $2,431	269 Added 14.89%	2,075 $16,000
Q2 2021 Aug 16, 2021	BUY	$6.39 - $11.51 $11,540 - $20,787	1,806 New	1,806 $16,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.